Alpheus Medical
@alpheusmedical
Followers
35
Following
12
Media
6
Statuses
12
Privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid #bodycancers. #glioblastoma #sonodynamictherapy
North Oakdale, MN
Joined March 2022
Big milestone: @AlpheusMedical raises $52M in oversubscribed Series B to advance our Phase 2b trial in newly diagnosed #GBM. Read more here: Our sonodynamic therapy is poised to transform brain tumor treatment. #medtech #braincancer #glioblastoma #oncology
0
1
4
#gliobastloma is a devastating diagnosis, but recent early #clinicaltrial data on our proprietary #SDT treatment shows new promise for newly diagnosed #GBM patients. Read more #braintumorresearch, #braintumorcommunity, #cancer #innovation
0
0
1
RT @mschulder: Presenting Alpheus CV101 results at #SNO2024. This was a phase 1 trial proving safety and also showing prolonged survival in….
0
1
0
We’re thrilled to announce positive results from our Phase 1/2 #clinicaltrial in #glioblastoma patients, presented at #SNO2024! Our groundbreaking #sonodynamictherapy (SDT) shows promising safety and early efficacy in targeting this devastating disease.
1
2
3
Going to #SNO2024 in Houston? Come hear our exciting Phase 1/2 #FIH results for #BrainCancerTreatment and learn about our proprietary #sonodynamictherapy (SDT) solution for #glioblastoma treatment. #CancerResearch #BrainCancer #NeuroOncology #BrainTumor #GlioblastomaResearch
0
2
4
Excited to share that our #gbm trial is underway and 3 patients have been treated with our novel, non-invasive #SDT therapy! Thanks to our partners, we are changing the landscape of #braincancer treatment. Learn more at
0
1
6
RT @BioWorldMedTech: .@alpheusgroup wins orphan drug and fast track designations to fight deadliest form of brain cancer .#Oncology.https:/….
0
1
0
Glioblastoma is the most common and deadliest type of #braincancer. It’s time to change the narrative. Learn more about how we are working to change it with our non-invasive solution at #GBM #gbmday
0
1
2
RT @HemOncToday: The @US_FDA granted fast track and orphan drug designations to @alpheusmedical’s CV-01 delivery of sonodynamic therapy for….
0
2
0
Excited to announce our Phase 1 #glioblastoma #clinicaltrial for non-invasive #sonodynamictherapy is now enrolling. We also received #FDA Orphan Drug and Fast Track designations. Learn how we aim to beat #braincancer. #GBM #BTSM.
0
3
7
Thrilled to announce our world-class scientific advisory board as we work to innovate therapies for #braincancer. Welcome to our team @roger_stupp MD, David Reardon MD, Walter Stummer MD, and @mathiassenge MD!. #glioblastoma.
1
4
11